These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 36089892)
1. Fanconi anemia caused by biallelic inactivation of BRCA2 can present with an atypical cancer phenotype in adulthood. Maxwell KN; Patel V; Nead KT; Merrill S; Clark D; Jiang Q; Wubbenhorst B; D'Andrea K; Cohen RB; Domchek SM; Morrissette JJD; Greenberg RA; Babushok DV; Nathanson KL Clin Genet; 2023 Jan; 103(1):119-124. PubMed ID: 36089892 [TBL] [Abstract][Full Text] [Related]
2. Inducibility of nuclear Rad51 foci after DNA damage distinguishes all Fanconi anemia complementation groups from D1/BRCA2. Godthelp BC; Wiegant WW; Waisfisz Q; Medhurst AL; Arwert F; Joenje H; Zdzienicka MZ Mutat Res; 2006 Feb; 594(1-2):39-48. PubMed ID: 16154163 [TBL] [Abstract][Full Text] [Related]
3. Biallelic BRCA2 mutations in two black South African children with Fanconi anaemia. Feben C; Spencer C; Lochan A; Laing N; Fieggen K; Honey E; Wainstein T; Krause A Fam Cancer; 2017 Jul; 16(3):441-446. PubMed ID: 28185119 [TBL] [Abstract][Full Text] [Related]
4. Cellular characterization of cells from the Fanconi anemia complementation group, FA-D1/BRCA2. Godthelp BC; van Buul PP; Jaspers NG; Elghalbzouri-Maghrani E; van Duijn-Goedhart A; Arwert F; Joenje H; Zdzienicka MZ Mutat Res; 2006 Oct; 601(1-2):191-201. PubMed ID: 16920162 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition. Seal S; Barfoot R; Jayatilake H; Smith P; Renwick A; Bascombe L; McGuffog L; Evans DG; Eccles D; Easton DF; Stratton MR; Rahman N; Cancer Res; 2003 Dec; 63(24):8596-9. PubMed ID: 14695169 [TBL] [Abstract][Full Text] [Related]
6. A novel splice site mutation in the noncoding region of BRCA2: implications for Fanconi anemia and familial breast cancer diagnostics. Bakker JL; Thirthagiri E; van Mil SE; Adank MA; Ikeda H; Verheul HM; Meijers-Heijboer H; de Winter JP; Sharan SK; Waisfisz Q Hum Mutat; 2014 Apr; 35(4):442-6. PubMed ID: 24395671 [TBL] [Abstract][Full Text] [Related]
7. Genotype-cancer association in patients with Fanconi anemia due to pathogenic variants in FANCD1 (BRCA2) or FANCN (PALB2). McReynolds LJ; Biswas K; Giri N; Sharan SK; Alter BP Cancer Genet; 2021 Nov; 258-259():101-109. PubMed ID: 34687993 [TBL] [Abstract][Full Text] [Related]
8. Pediatric acute promyelocytic leukemia and Fanconi anemia: Case report and literature review. Freycon C; Sepulchre E; Lavallée VP; Mitchell D; MacMillan ML; Vezina C; Goudie C Clin Genet; 2024 Aug; 106(2):193-198. PubMed ID: 38658784 [TBL] [Abstract][Full Text] [Related]
9. Biallelic inactivation of BRCA2 in Fanconi anemia. Howlett NG; Taniguchi T; Olson S; Cox B; Waisfisz Q; De Die-Smulders C; Persky N; Grompe M; Joenje H; Pals G; Ikeda H; Fox EA; D'Andrea AD Science; 2002 Jul; 297(5581):606-9. PubMed ID: 12065746 [TBL] [Abstract][Full Text] [Related]
10. Catastrophic chemotherapy toxicity leading to diagnosis of Fanconi anaemia due to Ip E; McNeil C; Grimison P; Scheinberg T; Tudini E; Ho G; Scott RJ; Brown C; Sandroussi C; Guitera P; Spurdle AB; Goodwin A J Med Genet; 2022 Sep; 59(9):912-915. PubMed ID: 34697207 [TBL] [Abstract][Full Text] [Related]
11. Fanconi anemia: causes and consequences of genetic instability. Kalb R; Neveling K; Nanda I; Schindler D; Hoehn H Genome Dyn; 2006; 1():218-242. PubMed ID: 18724063 [TBL] [Abstract][Full Text] [Related]
12. Assessing the spectrum of germline variation in Fanconi anemia genes among patients with head and neck carcinoma before age 50. Chandrasekharappa SC; Chinn SB; Donovan FX; Chowdhury NI; Kamat A; Adeyemo AA; Thomas JW; Vemulapalli M; Hussey CS; Reid HH; Mullikin JC; Wei Q; Sturgis EM Cancer; 2017 Oct; 123(20):3943-3954. PubMed ID: 28678401 [TBL] [Abstract][Full Text] [Related]
13. Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study. Kastellan S; Kalb R; Sajjad B; McReynolds LJ; Giri N; Samuel D; Milde T; Elbracht M; Holzhauer S; Niewisch MR; Kratz CP J Hematol Oncol; 2024 Apr; 17(1):26. PubMed ID: 38685107 [TBL] [Abstract][Full Text] [Related]
14. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Reid S; Schindler D; Hanenberg H; Barker K; Hanks S; Kalb R; Neveling K; Kelly P; Seal S; Freund M; Wurm M; Batish SD; Lach FP; Yetgin S; Neitzel H; Ariffin H; Tischkowitz M; Mathew CG; Auerbach AD; Rahman N Nat Genet; 2007 Feb; 39(2):162-4. PubMed ID: 17200671 [TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of FANCL, FANCM and the recently identified FANCI suggests that among the 13 known Fanconi Anemia genes, only FANCD1/BRCA2 plays a major role in high-risk breast cancer predisposition. García MJ; Fernández V; Osorio A; Barroso A; Fernández F; Urioste M; Benítez J Carcinogenesis; 2009 Nov; 30(11):1898-902. PubMed ID: 19737859 [TBL] [Abstract][Full Text] [Related]
16. Breast cancer and Fanconi anemia: what are the connections? Zdzienicka MZ; Arwert F Trends Mol Med; 2002 Oct; 8(10):458-60. PubMed ID: 12383764 [TBL] [Abstract][Full Text] [Related]
17. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1. Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460 [TBL] [Abstract][Full Text] [Related]
18. The clinical phenotype of children with Fanconi anemia caused by biallelic FANCD1/BRCA2 mutations. Myers K; Davies SM; Harris RE; Spunt SL; Smolarek T; Zimmerman S; McMasters R; Wagner L; Mueller R; Auerbach AD; Mehta PA Pediatr Blood Cancer; 2012 Mar; 58(3):462-5. PubMed ID: 21548014 [TBL] [Abstract][Full Text] [Related]
19. Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia. Offit K; Levran O; Mullaney B; Mah K; Nafa K; Batish SD; Diotti R; Schneider H; Deffenbaugh A; Scholl T; Proud VK; Robson M; Norton L; Ellis N; Hanenberg H; Auerbach AD J Natl Cancer Inst; 2003 Oct; 95(20):1548-51. PubMed ID: 14559878 [TBL] [Abstract][Full Text] [Related]
20. A novel cancer risk prediction score for the natural course of FA patients with biallelic BRCA2/FANCD1 mutations. Radulovic I; Schündeln MM; Müller L; Ptok J; Honisch E; Niederacher D; Wiek C; Scheckenbach K; Leblanc T; Larcher L; Soulier J; Reinhardt D; Schaal H; Andreassen PR; Hanenberg H Hum Mol Genet; 2023 May; 32(11):1836-1849. PubMed ID: 36721989 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]